Whole-body MRI for the Detection of Metastasis

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02183597

Acronym

WBMRI

Enrollment

Registered

2014-07-08

Start date

2016-03-31

Completion date

2018-03-31

Last updated

2016-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Metastases

Keywords

Magnetic Resonance Imaging, Data Accuracy, Reproducibility of Results, Diagnosis

Brief summary

Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 95 Years

Healthy volunteers

Inclusion criteria

\- Cancer patient

Exclusion criteria

* Poor general condition * Pacemaker or other MRI contraindications

Design outcomes

Primary

Measure	Time frame	Description
Number of metastasis in skeleton	Baseline and after 6 months	Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease

Outcome results